Analysts Split on Health In Tech as Losses Persist Through 2027
Wall Street's read on Health In Tech, Inc. (NASDAQ: HIT) remains anything but settled. Maxim Group analyst A. Klee issued a fresh round of quarterly estimates on Friday, August 14th, projecting a
